Patent watch: Supreme Court decision favours biosimilars

Nature Reviews Drug Discovery 16, 521 (2017).
doi:10.1038/nrd.2017.136

Author: Courtenay C. Brinckerhoff
On June 12, 2017, the US Supreme Court issued a unanimous decision in Sandoz Inc. v. Amgen Inc. (No. 15-1039), providing its first interpretation of the patent dispute resolution provisions of the Biologics Price Competition and Innovation Act (BPCIA). The Court essentially held that

Source: Nature Reviews Drug Discovery - July 31, 2017 Category: Drugs & Pharmacology Authors: Courtenay C. Brinckerhoff Tags: News and Analysis Source Type: research